Cardiac Pacemakers, Inc.

The UAB Research Foundation (The University of Alabama at Birmingham)

Other

Boston Scientific Scimed, Inc.

Duke University

Mayo Foundation for Medical Education and Research

Stephen John Hahn

Krzysztof Z Siejko

Keith L Herrmann

Venugopal Allavatam

Amy Jean Brisben

Deepa Mahajan

David K Swanson

Bruce H KenKnight

Keith R Maile

Allan Charles Shuros

Roger W Dahl

Douglas J Lang

John E Heil

Pramodsingh Hirasingh Thakur

Qi An

Ramesh Wariar

Brendan Early Koop

Viktoria A Averina

Raymond E Ideker

Kevin G Wika

Jay A Warren

Jason J Hamann

David J Ternes

G Shantanu Reddy

Mitchell D Lanz

Robert S Booker, Iii

Benjamin Speakman

Qingsheng Zhu

Yinghong Yu

William J Linder

Benjamin J Haasl

James O Gilkerson

Arthur J Foster

Shantha Arcot-Krishnamurthy

Yanting Dong

Kenneth Paul Hoyme

Andrew L De Kock

Steven D Girouard

Juan Gabriel Hincapie Ordonez

Gregory P Walcott

Moira B Sweeney

Haresh G Sachanandani

Wyatt Keith Stahl

Robert D Brock, Ii

David L Perschbacher

Gerrard Merrill Carlson

Stephen B Ruble

Dan Li

Shibaji Shome

James P Rohl

Bin Mi

David Arthur Casavant

Douglas Dean Pagoria

Arjun D Sharma

Sarah Melissa Gruba

Suraj Kapa

Bryan J Swackhamer

Scott J Healy

John Mark Morgan

Chance M Witt

Paul Freer

Peter Toy

Kenneth Matrin Stein

Michael L'Ecuyer

Alexandra Verne

Morgan Bohrer

Kaith L Herrmann

Kenneth M Stein

A device for biofilm removal from an endotracheal tube is disclosed. Such a device may include a hollow catheter having a tip, wherein said device is inserted down an endotracheal tube of an orally intubated patient. Said tip may include a cylindrical central portion and a fin configured to dislodge biofilm from the inner lumen of the endotracheal tube as the device is rotated, either manually or mechanically, inside the endotracheal tube. The fin may be configured as a helix and positioned to spiral around said cylindrical central portion of the tip thereby forming a channel, defined by the pitch of said helix, about the circumference of the cylindrical central portion. Biofilm dislodged from the inner surface of the endotracheal tube by the rotational motion of the fin may be retained within the channel until the tip is removed from the endotracheal tube. The device may further comprise a motor for mechanically rotating the catheter and tip. Finally, the device may be configured to interface with a mechanical ventilator such that airflow to an intubated patient is not impeded while said device is used to remove biofilm from the inner surface of the patient's endotracheal tube.

Biofilm removal device for endotracheal tubes

Systems and methods for cardiac pacing are described in this document. A medical system includes an electrostimulation circuit to generate His-bundle pacing (HBP) pulses to capture a His bundle, and LV pacing (LVP) pulses to capture a left ventricle. A sensing circuit may sense a cardiac activity, such as an atrial or an LV cardiac electrical activity. The system includes a control circuit controlling the delivery of HBP and LVP pulses. The HBP and LVP may be delivered concurrently or sequentially. In an example, the LVP pulses may be delivered based on a His-bundle capture status in response to the HBP pulse. The system may adjust one or more His-bundle stimulation parameters based on the His-bundle capture status.

His-bundle pacing system with left-ventricular pacing

A medical device system has a medical device interface configured to download data from an implanted medical device. Memory stores electrode location identification rules and display definitions. Each of the display definitions correspond to possible electrode placement locations of the implanted medical device. Processing circuitry is configured to compare the downloaded data from the implanted medical device to the electrode location identification rules to identify one or more actual electrode placement locations of the possible electrode placement locations of the implanted medical device. A user output interface is in communication with the processing circuitry. The processing circuitry is configured to cause the output to display the one or more actual electrode placement locations.

Identification of implanted electrode location

In various aspects, the present disclosure provides methods for applying ablation therapy to a target tissue region within a patient, which methods include: (a) navigating a catheter to a target tissue region within the patient, the catheter including an elongate body having a proximal portion and a distal portion and a balloon structure positioned at the distal portion of the elongate body, which balloon structure may be permeable to a calcium-ion-containing solution that comprises one or more calcium salts; (b) positioning the balloon structure at the target tissue region; (c) delivering energy to the target tissue region; and (d) eluting the calcium-ion-containing solution from the balloon structure before, during, and/or after delivering the energy to the target tissue region. In various other aspects, the present disclosure provides apparatuses that can be used for performing such methods, among others.

Calcium electroporation delivery apparatus and method

Methods and/or device facilitating and selecting among multiple modes of filtering a cardiac electrical signal, in which one filtering mode includes additional high pass filtering of low frequency signals, relative to the other filtering mode. The selection filtering modes may include comparing sensed signal amplitude to one or more thresholds, using the multiple modes of filtering. In another example, an additional high pass filter is enabled, over and above a default or baseline filtering mode, and the detected cardiac signal is monitored for indications of possible undersensing, and/or for drops in amplitude toward a threshold, and the additional high pass filter may be disabled upon finding of possible undersensing or drop in signal amplitude.

Automatic determination and selection of filtering in a cardiac rhythm management device

A device for the active fixation of an implantable medical lead includes a housing, a tine assembly, an electrode, and a rotatable shaft. The housing includes a proximal end for connecting to the lead and a distal end opposite the proximal end. The housing defines a housing lumen extending between the proximal end and a recess adjacent to the distal end. The tine assembly is disposed within the housing lumen and includes at least one tine configured to self-bias from a linear configuration within the housing to a curved configuration outside of the housing. The electrode assembly is disposed at the distal end of the housing and includes a plurality of electrodes. The rotatable shaft extends through the housing lumen and is configured to engage the tine assembly such that rotation of the shaft transitions the at least one tine between the linear configuration and the curved configuration.

Multipolar lead for His bundle pacing

Systems, methods and implantable devices configured to provide cardiac resynchronization therapy and/or bradycardia pacing therapy. A first device located in the heart of the patient is configured to receive a communication from a second device and deliver a pacing therapy in response to or in accordance with the received communication. A second device located elsewhere is configured to determine an atrial event has occurred and communicate to the first device to trigger the pacing therapy. The second device may be configured for sensing the atrial event by the use of vector selection and atrial event windowing, among other enhancements. Exception cases are discussed and handled as well.

Cardiac therapy system using subcutaneously sensed p-waves for resynchronization pacing management

Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker (LCP) and an extracardiac device (ED). The LCP is configured to deliver pacing therapy at a pacing interval. Illustratively, the ED may be configured to analyze the cardiac cycle including a portion preceding the pacing therapy delivery for one or several cardiac cycles, and determine whether an interval from the P-wave to the pace therapy in the cardiac cycle(s) is in a desired range. In an example, if the P-wave to pace interval is outside the desired range, the ED communicates to the LCP to adjust the pacing interval.

Integrated multi-device cardiac resynchronization therapy using p-wave to pace timing

This document discusses, among other things, systems and methods to generate a first pacing waveform during a first pacing period and a second pacing waveform during a second pacing period, to alternate first and second pacing periods to provide pacing-based hypertension therapy to a heart of a patient to reduce patient blood pressure, to receive information indicative of patient metabolic demand, and to determine an adjusted pacing-based hypertension therapy parameter using the received information indicative of patient metabolic demand, wherein the first pacing waveform has a first atrioventricular (AV) delay and the second pacing waveform has a second AV delay longer than the first AV delay.

Pacing-based hypertension therapy metabolic demand adjustment

Multipolar lead for his bundle pacing

This document discusses, among other things, systems and methods to receive physiologic information from a patient during different first and second pacing periods having respective, different first and second atrioventricular (AV) delays, determine first and second physiologic parameters using respective received physiologic information from the first and second pacing periods, and adjust the first AV delay using the determined first and second physiologic parameters, wherein the second AV delay is longer than the first AV delay.

Patterned pacing to reduce hypertension

New and alternative approaches to the monitoring of cardiac signal quality for external and/or implantable cardiac devices. In one example, signal quality is monitored continuously or in response to a triggering event or condition and, upon identification of a reduction in signal quality, a device may reconfigure its sensing state. In another example, one or more trends of signal quality are monitored by a device, either continuously or in response to a triggering event or condition, and sensing reconfiguration may be performed in response to identified trends and events. In yet another example, a device may use a looping data capture mode to track sensing data in multiple vectors while primarily relying on less than all sensing vectors to make decisions and, in response to a triggering event or condition, the looped data can be analyzed automatically, without waiting for additional data capture to reconfigure sensing upon identification of the triggering event or condition. In another example a device calculates a composite cardiac cycle by overlaying signal morphology for a number of cardiac cycles and analyzes the composite cardiac cycle to calculate signal quality metrics.

Signal quality monitoring for multiple sense vectors in cardiac devices

A subcutaneous implantable cardioverter-defibrillator (S-ICD) comprising shocking electrodes configured to reduce the defibrillation threshold. The S-ICD may include a canister housing a source of electrical energy, a capacitor, and operational circuitry that senses heart rhythms and an electrode and lead assembly. The electrode and lead assembly may comprise a lead, at least one sensing electrode, and at least one shocking electrode. The at least one shocking electrode may extend over a length in the range of 50 to 110 millimeters and a width in the range of 1 to 40 millimeters.

Electrode designs in implantable defibrillator systems

This document discusses, among other things, systems and methods to generate a first pacing waveform during a first pacing period and a second pacing waveform during a second pacing period, and alternate the first and second pacing periods to provide pacing-based hypertension therapy to a heart of a patient to reduce patient blood pressure, wherein the first pacing waveform has a first atrioventricular (AV) delay and the second pacing waveform has a second AV delay longer than the first AV delay. Physiologic information can be received from the patient, and one of the first or second pacing period for delivery to the patient can be determined using the received physiologic information.

Pacing-based hypertension therapy safety

An example of a system and method for protecting a patient diagnosed of cancer from cardiac injury resulting from a chemotherapy treating the cancer. A sequence of cardioprotective pacing sessions may be initiated based on timing of the chemotherapy. Cardiac pacing pulses may be delivered to the patient during each session of the cardioprotective pacing sessions according to a cardioprotective pacing mode for controlling delivery of the cardiac pacing pulses to effect cardioprotection against potential myocardial injury resulting from the chemotherapy. The cardioprotective pacing mode may specifying alternating non-pacing and pacing periods.

Pacing method and system for cardioprotection during chemotherapy

Growing community of inventors

Shoreview, MN, United States of America

Stephen John Hahn